2021
DOI: 10.1164/rccm.202010-3899ed
|View full text |Cite
|
Sign up to set email alerts
|

Defining the Clinical Utility of the Lung Clearance Index. Are We There Yet?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…The lung clearance index (LCI) is a sensitive physiological outcome measure and is a potentially useful diagnostic tool to guide treatment decisions in children with early cystic fibrosis lung disease (CF) 1 2. In a prospective observational study, we showed that LCI is more sensitive than FEV 1 in detecting worsening lung function and treatment effects in preschool and school-age children with acute respiratory symptoms 3–6.…”
Section: Introductionmentioning
confidence: 99%
“…The lung clearance index (LCI) is a sensitive physiological outcome measure and is a potentially useful diagnostic tool to guide treatment decisions in children with early cystic fibrosis lung disease (CF) 1 2. In a prospective observational study, we showed that LCI is more sensitive than FEV 1 in detecting worsening lung function and treatment effects in preschool and school-age children with acute respiratory symptoms 3–6.…”
Section: Introductionmentioning
confidence: 99%
“…Evidence collected so far has recognized LCI as an outcome measure in interventional trials [ 3 5 ]. Only recently, LCI was found sensitive to assess CF disease progression without overt clinical symptoms [ 6 ], however the utility of LCI as a clinical marker to guide the multidisciplinary practice of the CF team is still a matter of discussion [ 7 , 8 ]. Considering that personalized medicine not only aims to target therapies but also to identify individuals at elevated risk that could benefit most from therapies, we hypothesized that LCI can help to characterize clinical phenotypes of children with CF with regards to severity of lung disease.…”
Section: Introductionmentioning
confidence: 99%
“…Data on variability and clinically and physiologically relevant changes are essential for the use of LCI in the clinical surveillance of CF lung disease and to guide therapeutic decisions 19 . This study adds important data on the variability of LCI in routine clinical surveillance.…”
Section: Discussionmentioning
confidence: 95%